Risk of Hodgkin lymphoma according to immigration status and origin: a migrant cohort study of 2.3 million Jewish Israelis

References

• Landgren O, Caporaso NE. New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin’s lymphoma. Hematol Oncol Clin North Am. 2007;21:825–840.
   PubMed Web of Science ®Google Scholar
• Swerdllow S, Campo E, Harris NL. WHO classification of tumors of hematopoietic and lymphoid tissues. France: IARC Press, 2008.
   Google Scholar
• Punnett A, Tsang RW, Hodgson DC. Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects. Semin Radiat Oncol. 2010;20:30–44.
   PubMed Web of Science ®Google Scholar
• Kenneth K, Marshall AL, Ernest B, et al. Williams hematology. 8th ed. Textbook; 2010.
   Google Scholar
• Hjalgrim H, Smedby KE, Rostgaard K, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res. 2007;67:2382–2388.
   PubMed Web of Science ®Google Scholar
• Crump C, Sundquist K, Sieh W, et al. Perinatal and family risk factors for Hodgkin lymphoma in childhood through young adulthood. Am J Epidemiol. 2012;176:1147–1158.
   PubMed Web of Science ®Google Scholar
• Mack TM, Norman JE Jr, Rappaport E, et al. Childhood determination of Hodgkin lymphoma among U.S. servicemen. Cancer Epidemiol Biomarkers Prev. 2015;24:1707–1715.
   PubMed Web of Science ®Google Scholar
• Gutensohn N, Cole P. Epidemiology of Hodgkin’s disease in the young. Int J Cancer. 1977;19:595–604.
   PubMed Web of Science ®Google Scholar
• Hjalgrim H. On the etiology of Hodgkin lymphoma. Danish Med J. 2012;59:B4485.
   PubMed Web of Science ®Google Scholar
• Engeland A, Tretli S, Hansen S, et al. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol. 2007;165:44–52.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer. 2011;47:2422–2430.
   PubMed Web of Science ®Google Scholar
• Sergentanis TN, Kanavidis P, Michelakos T, et al. Cigarette smoking and risk of lymphoma in adults: a comprehensive meta-analysis on Hodgkin and non-Hodgkin disease. Eur J Cancer Prev. 2013;22:131–150.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Dalia S, Shum H. Meta-analysis of the association between cigarette smoking and incidence of Hodgkin’s Lymphoma. J Clin Oncol. 2011;29:3900–3906.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• GLOBOCAN. Estimated cancer incidence mortality and prevalence worldwide in 2012. 2012. Available from: http://globocan.iarc.fr/Pages/Map.aspx.
   Google Scholar
• Israel National Cancer Institute website. Hodgkin Lymphoma Incidence Table; 2013 [cited 2016 Jul 26]. Available from: http://www.health.gov.il/UnitsOffice/HD/ICDC/ICR/CancerIncidence/Pages/Hodgkin-Lymphoma.aspx
   Google Scholar
• Ariad S, Lipshitz I, Benharroch D, et al. A sharp rise in the incidence of Hodgkin's lymphoma in young adults in Israel. Israel Med Assoc J. 2009;11:453–455.
   PubMed Web of Science ®Google Scholar
• Winter H, Cheng KK, Cummins C, et al. Cancer incidence in the south Asian population of England (1990–92). Br J Cancer. 1999;79:645–654.
   PubMed Web of Science ®Google Scholar
• Au WY, Gascoyne RD, Gallagher RE, et al. Hodgkin’s lymphoma in Chinese migrants to British Columbia: a 25-year survey. Ann Oncol. 2004;15:626–630.
   PubMed Web of Science ®Google Scholar
• Evens AM, Antillón M, Aschebrook-Kilfoy B, et al. Racial disparities in Hodgkin's lymphoma: a comprehensive population-based analysis. Ann Oncol. 2012;23:2128–2137.
   PubMed Web of Science ®Google Scholar
• Levine H, Huerta-Hartal M, Bar-Ze'ev Y, et al. Smoking and other correlates of health care services utilization among mandatory military recruits in Israel. Nicotine Tob Res. 2012;14:742–750.
   PubMed Web of Science ®Google Scholar
• Levine H, Afek A, Shamiss A, et al. Country of origin, age at migration and risk of cutaneous melanoma: a migrant cohort study of 1,100,000 Israeli men. Int J Cancer. 2013;133:486–494.
   PubMed Web of Science ®Google Scholar
• Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000;314:1–27.
   PubMedGoogle Scholar
• Iscovich JM, Parkin DM. Risk of cancer in migrants and their descendants in Israel: I. leukaemias and lymphomas. Int J Cancer. 1997;70:649–653.
   PubMed Web of Science ®Google Scholar
• Abramson JH, Goldblum N, Avitzur M, et al. Clustering of Hodgkin's disease in Israel: a case-control study. Int J Epidemiol. 1980;9:137–144.
   PubMed Web of Science ®Google Scholar
• Glaser SL, Chang ET, Clarke CA, et al. Hodgkin lymphoma incidence in ethnic enclaves in California. Leukemia Lymphoma. 2015;56:3270–3280.
   PubMed Web of Science ®Google Scholar
• Glaser SL, Clarke CA, Chang ET, et al. Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus. Cancer Causes Control. 2014;25:709–725.
   PubMed Web of Science ®Google Scholar
• Hanson MA, Gluckman PD. Developmental origins of health and disease: new insights. Basic Clin Pharmacol Toxicol. 2008;102:90–93.
   PubMed Web of Science ®Google Scholar
• Li J, Vestergaard M, Obel C, et al. Antenatal maternal bereavement and childhood cancer in the offspring: a population-based cohort study in 6 million children. Br J Cancer. 2012;107:544–548.
   PubMed Web of Science ®Google Scholar
• Ostrer H, Skorecki K. The population genetics of the Jewish people. Hum Genet. 2013;132:119–127.
   PubMed Web of Science ®Google Scholar
• Diepstra A, Niens M, te Meerman GJ, et al. Genetic susceptibility to Hodgkin’s lymphoma associated with the human leukocyte antigen region. Eur J Haematol Suppl. 2005;75(Suppl. 66):34–41.
   Google Scholar
• Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin’s lymphoma. Lancet. 2005;365:2216–2224.
   PubMed Web of Science ®Google Scholar
• Johnson PC, McAulay KA, Montgomery D, et al. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. Int J Cancer. 2015;137:1066–1075.
   PubMed Web of Science ®Google Scholar
• Urayama KY, Jarrett RF, Hjalgrim H, et al. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst. 2012;104:240–253.
   PubMed Web of Science ®Google Scholar
• Meydan C, Afek A, Derazne E, et al. Population-based trends in overweight and obesity: a comparative study of 2,148,342 Israeli male and female adolescents born 1950-1993. Pediatr Obes. 2013;8:98–111.
   PubMed Web of Science ®Google Scholar
• Kutok JL, Wang F. Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol. 2006;1:375–404.
   PubMed Web of Science ®Google Scholar
• Levine H, Balicer RD, Rozhavski V, et al. Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults. Ann Epidemiol. 2012;22:783–788.
   PubMed Web of Science ®Google Scholar
• Levine H, Mimouni D, Grotto I, et al. Secular and seasonal trends of infectious mononucleosis among young adults in Israel: 1978-2009. Eur J Clin Microbiol Infect Dis. 2012;31:757–760.
   PubMed Web of Science ®Google Scholar
• Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med. 2003;349:1324–1332.
   PubMed Web of Science ®Google Scholar
• Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer. 1997;70:375–382.
   PubMed Web of Science ®Google Scholar
• Benharroch D, Brousset P, Goldstein J, et al. Association of the Epstein-Barr virus with Hodgkin’s disease in Southern Israel. Int J Cancer. 1997;71:138–141.
   PubMed Web of Science ®Google Scholar
• Shimabukuro-Vornhagen A, Haverkamp H, Engert A, et al. Lymphocyte-rich classical Hodgkin’s lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin’s Study Group trials. J Clin Oncol. 2005;23:5739–5745.
   PubMed Web of Science ®Google Scholar